| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.84 | 0.0006 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |